LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
about
Targeting innate immunity for neurodegenerative disorders of the central nervous systemFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic ratsFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's diseaseIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyCurcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseNon-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathwaysNeuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyA Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to DiseaseAmeliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain InjuryHistone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition.Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer's pathologyR-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.Glial contributions to neurodegeneration in tauopathies.Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young miceEpitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis.Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.The role of tau protein in HIV-associated neurocognitive disordersLipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseasesNew perspectives for natural antimicrobial peptides: application as antinflammatory drugs in a murine modelInflammasomes as therapeutic targets for Alzheimer's disease.Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.Expression of Tau40 induces activation of cultured rat microglial cells.Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.Lipopolysaccharide-induced tau phosphorylation and kinase activity--modulation, but not mediation, by corticotropin-releasing factor receptors.Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathyImpact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.Protective Effect of RNase on Unilateral Nephrectomy-Induced Postoperative Cognitive Dysfunction in Aged MiceNeuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats.Microglial malfunction: the third rail in the development of Alzheimer's disease.Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration.Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokinesSuppression of LPS-induced tau hyperphosphorylation by serum amyloid A.Neuroinflammatory phenotype in early Alzheimer's disease.The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.Thinking laterally about neurodegenerative proteinopathies.Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain.Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
P2860
Q26744219-84457C79-8473-4B8E-8049-7B7324DA6A26Q26747585-45BCB7A7-21EE-4682-92DC-0659F6AC2A51Q26748713-75DBD93C-FFAF-49FE-BBDD-9D1051C65BE9Q26775404-2254BAFE-8C4E-430D-858B-A2CA9A3BAF83Q26781090-C136E51C-9C3A-49F6-A59B-2BCF54E045FFQ26822022-2299383B-6274-4422-AC06-BFCFDE8E9DACQ26830542-78EB55F9-B926-4EC5-8B44-EB92531E433BQ27014919-6665ADBF-5D32-4814-84F9-F19612379264Q29248210-64EC44F6-D598-40BB-8115-D8E26E700426Q30387426-4237D6D0-3EE4-4C4D-960D-4C7D7A066F07Q30440318-67513672-25A8-4C28-A1AF-D88DB326B675Q30448973-5404D2E5-C4D3-4610-828C-41063E3D5BDFQ30684317-32833120-2644-4A89-9BBF-330B07DB731FQ32173558-E45CCDD7-18C5-4143-ACCF-4FBDB732D839Q34195717-5B537CF9-CC54-4CAE-909D-95A9D13A00E7Q34205027-C67CB892-89F6-4CCC-9C2A-88F1B587FB26Q34227162-6187E297-8854-41EF-B0E5-3BC0FDE4B57DQ34410713-44F37DA3-7903-4E18-9ED0-8F9B9ECB3206Q34412996-6862222B-5962-487A-AA1B-4A94CA3F7CD5Q34418045-EF210332-6A3A-4916-B922-CB31D4F83D3AQ34479717-92C790B8-C751-42AD-B91D-AF9808FF53A6Q34547897-ABDE2B87-3261-462E-B3C0-0BA03B2F9AE3Q34774194-229722D7-D9EF-45F0-B894-098AC24E195DQ35022620-C7392EE3-A4CD-4EF1-A1C7-D2F24EDF06F8Q35043731-8AE57225-2C36-4AB5-91F9-29423DEC1B03Q35141280-103765A7-2D41-466A-B352-7832A7C3D627Q35158609-61E9E581-2437-4571-9898-97CD00D4528DQ35694088-48C1F502-A8E5-4684-863A-C3B1F03D417AQ35726240-87E31CF1-164D-429E-A7EA-170DD96D30EFQ36255465-B169C2B4-2D46-48DD-89EF-298652FCDD79Q36348184-7C21955F-B1B3-4204-90F0-6150BBE37524Q36376140-F4B37BD4-BC50-4D31-A94A-9BA2829AEEE4Q36457510-9020F71D-E976-47DA-99F1-4D26814BEC43Q36529499-9BF0547F-2979-4772-A19E-0C3F4A09CB89Q36629135-F28FA7AC-697F-418B-AD73-C0F106BF797EQ36646116-841EA791-BF93-45AC-B30A-530B7A4F988AQ36793466-F756A930-7825-4EFD-9D59-53013BFCE001Q36799810-E338C77E-D7F1-4473-BF86-B238A3E81F17Q37053459-F6F3E0B7-6D7F-4BE7-8B87-5C3FC1D69F4CQ37084011-AB009DD5-7B96-46AB-906F-68C73AE383F7
P2860
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@ast
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@en
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@nl
type
label
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@ast
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@en
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@nl
prefLabel
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@ast
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@en
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@nl
P2093
P2860
P356
P1476
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
@en
P2093
Amelia Johnson
Chad A Dickey
Clara Kraft
Daniel C Lee
Dave Morgan
Justin Rizer
Maj-Linda B Selenica
Marcia N Gordon
Patrick Reid
P2860
P2888
P356
10.1186/1742-2094-7-56
P50
P577
2010-09-16T00:00:00Z
P5875
P6179
1019856959